These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7768498)

  • 21. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
    Radaeva S; Ferreira-Gonzalez A; Sirica AE
    Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin.
    Saitoh K; Takahashi H; Sawada N; Parsons PG
    J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of the liver.
    Annen K; Nojima T; Hata Y; Uchino J; Tanaka S; Matsuda M; Tahara E; Nagashima K
    Gen Diagn Pathol; 1996 Mar; 141(3-4):179-86. PubMed ID: 8705780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S
    Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
    Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H
    Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
    Brunt EM; Swanson PE
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S53-61. PubMed ID: 1374219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
    Nakamura T
    Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
    Rong S; Oskarsson M; Faletto D; Tsarfaty I; Resau JH; Nakamura T; Rosen E; Hopkins RF; Vande Woude GF
    Cell Growth Differ; 1993 Jul; 4(7):563-9. PubMed ID: 8398896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells.
    Ivan M; Bond JA; Prat M; Comoglio PM; Wynford-Thomas D
    Oncogene; 1997 May; 14(20):2417-23. PubMed ID: 9188856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.
    Park WS; Dong SM; Kim SY; Na EY; Shin MS; Pi JH; Kim BJ; Bae JH; Hong YK; Lee KS; Lee SH; Yoo NJ; Jang JJ; Pack S; Zhuang Z; Schmidt L; Zbar B; Lee JY
    Cancer Res; 1999 Jan; 59(2):307-10. PubMed ID: 9927037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
    Nakashiro K; Hayashi Y; Oyasu R
    Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
    Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
    Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
    Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript.
    Moghul A; Lin L; Beedle A; Kanbour-Shakir A; DeFrances MC; Liu Y; Zarnegar R
    Oncogene; 1994 Jul; 9(7):2045-52. PubMed ID: 8208549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.